These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33464558)

  • 41. Efficacy of 0.19 mg Fluocinolone Acetonide Implant in Non-infectious Posterior Uveitis Evaluated as Area Under the Curve.
    Battista M; Starace V; Cicinelli MV; Capone L; Marchese A; Modorati G; Bandello F; Miserocchi E
    Ophthalmol Ther; 2022 Feb; 11(1):215-224. PubMed ID: 34787827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Follow-Up of Patient with Diabetic Macular Edema Receiving Fluocinolone Acetonide Intravitreal Implant.
    Bertelmann T; Schulze S
    Ophthalmol Ther; 2015 Jun; 4(1):51-8. PubMed ID: 25672501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Clinical Outcomes of the 0.18 Mg Fluocinolone Acetonide Intravitreal Implant Following Local Corticosteroid Burst in Noninfectious Uveitis.
    Janetos TM; Koreishi A; Goldstein DA
    Ocul Immunol Inflamm; 2024 Jan; ():1-6. PubMed ID: 38194443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center.
    Abu Arif J; Knecht VA; Rübsam A; Lussac V; Jami Z; Pohlmann D; Müller B; Pleyer U
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Intraocular Therapy in Non-infectious Uveitis of the Posterior Segment of the Eye.
    Mikhail M; Sallam A
    Med Hypothesis Discov Innov Ophthalmol; 2013; 2(4):113-20. PubMed ID: 24822232
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis.
    Park JG; Callaway NF; Ludwig CA; Mahajan VB
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100859. PubMed ID: 32793845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case Series Investigating the Efficacy and Safety of Bilateral Fluocinolone Acetonide (ILUVIEN(®)) in Patients with Diabetic Macular Edema.
    Elaraoud I; Attawan A; Quhill F
    Ophthalmol Ther; 2016 Jun; 5(1):95-104. PubMed ID: 26885863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
    Patel CC; Mandava N; Oliver SC; Braverman R; Quiroz-Mercado H; Olson JL
    Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
    Chieh JJ; Carlson AN; Jaffe GJ
    Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of fluocinolone acetonide intravitreal implant to manage chronic panuveitis for long-term inflammatory control without interfering with systemic immunity.
    Chang PY
    Digit J Ophthalmol; 2022; 28(4):119-125. PubMed ID: 36660185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.
    Steeples LR; Anand N; Moraji J; Jones NP
    Ocul Immunol Inflamm; 2018; 26(7):997-1004. PubMed ID: 28318344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series.
    Schmit-Eilenberger VK
    Clin Ophthalmol; 2015; 9():801-11. PubMed ID: 25999689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of data characterizing the clinical effectiveness of the fluocinolone intravitreal implant (ILUVIEN) in patients with diabetic macular edema from the real world, non-interventional ICE-UK study and the FAME randomized controlled trials.
    Holden SE; Kapik B; Beiderbeck AB; Currie CJ
    Curr Med Res Opin; 2019 Jul; 35(7):1165-1176. PubMed ID: 30569759
    [No Abstract]   [Full Text] [Related]  

  • 55. Fluocinolone acetonide for the treatment of diabetic macular edema.
    Veritti D; Sarao V; Diplotti L; Samassa F; Lanzetta P
    Expert Opin Pharmacother; 2017 Oct; 18(14):1507-1516. PubMed ID: 28764565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.
    Sadiq MA; Agarwal A; Soliman MK; Hanout M; Sarwar S; Do DV; Nguyen QD
    Expert Opin Drug Saf; 2015 Jul; 14(7):1147-56. PubMed ID: 25994877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Macular oedema and intravitreal triamcinolone injections].
    Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
    Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.